People · Operator

David W. Ko

Named in public records as an officer, director or promoter · active 2013–2013 · Other Health Care

1
Companies
1
Filings
$70.4M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Audax Health Solutions, Inc.Other Health CareSeries B$70.4M$642.0M2013
Operator network

David W. Ko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Craig W. Thomas · 2 companies · 1 sharedCraig W. ThomasBob W. Kaplan · 1 companies · 1 sharedBob W. KaplanBrian W. Dolan · 1 companies · 1 sharedBrian W. DolanGrant Lovely Verstandig · 1 companies · 1 sharedGrant Lovely Vers…James Homer Roberts Brady · 1 companies · 1 sharedJames Homer Rober…J. Miles Reidy · 1 companies · 1 sharedJ. Miles ReidyJohn Wallis Rowe · 1 companies · 1 sharedJohn Wallis RoweJohn W. Sculley · 1 companies · 1 sharedJohn W. SculleyJohn W. Scully · 1 companies · 1 sharedJohn W. ScullyMark W. Boxer · 1 companies · 1 sharedMark W. BoxerNick W. Augustinos · 1 companies · 1 sharedNick W. AugustinosRichard D. Klausner · 1 companies · 1 sharedRichard D. Klausn…Roger W. Ferguson, Jr. · 1 companies · 1 sharedRoger W. Ferguson…Audax Health Solutions, Inc. · $70.4M raisedAudax Health Solution…David W. KoDK
David W. Ko Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David W. Ko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Craig W. Thomas12
John W. Sculley11
Grant Lovely Verstandig11
Richard D. Klausner11
Roger W. Ferguson, Jr.11
Nick W. Augustinos11
J. Miles Reidy11
John Wallis Rowe11
James Homer Roberts Brady11
Brian W. Dolan11
Bob W. Kaplan11
Mark W. Boxer11
John W. Scully11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.